United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 8, 2026 · Filed May 11, 2026

On May 8, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$564.95 for US$5.37M under a trading plan, leaving 40,513 shares. Filed May 11, 2026 (Form 4).

Sold
9,500 shares
Price
US$564.95 average (US$562.08 to US$571.66)
Value
US$5.37M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 8, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 8, 2026Common StockSale1,126US$562.0848,887Direct
May 8, 2026Common StockSale2,022US$563.0646,865Direct
May 8, 2026Common StockSale1,864US$564.0045,001Direct
May 8, 2026Common StockSale1,983US$564.7743,018Direct
May 8, 2026Common StockSale705US$565.9942,313Direct
May 8, 2026Common StockSale319US$567.2141,994Direct
May 8, 2026Common StockSale360US$568.1641,634Direct
May 8, 2026Common StockSale106US$569.6141,528Direct
May 8, 2026Common StockSale495US$570.2241,033Direct
May 8, 2026Common StockSale520US$571.6640,513Direct

Source

View original at SEC

Related